The expression of prosaposin is temporally and spatially regulated at the transcriptional and post-translational levels. In itro, the mouse prosaposin promoter contains functional RORE [retinoic acid-receptor-related orphan receptor α subunit (RORα)-binding element], Sp1 and U (unknown) sites within 310 bp directly 5h to the transcription start site and additional elements within 2400 bp 5h to the transcription start site. To elucidate promoter regions important to tissue-preferential expression in i o, transgenic mice were created with 5h-flanking deletions of the prosaposin gene fused to a luciferase reporter. Nearly exclusive expression was observed in cerebrum, cerebellum and eyes of adult transgenic mice containing constructs with 234-310 bp of 5h-flanking DNA. This central nervous system (CNS) expression was due to the presence of RORE and overlapping Sp1 sites in this region. Internal deletion of RORE
INTRODUCTION
Prosaposin is a multifunctional protein with essential intra-and extra-cellular functions. Intracellularly, prosaposin (522 amino acids), the precursor, is targeted to lysosomes via the mannose-6-phosphate-receptor-dependent and\or -independent systems where it is proteolytically processed to smaller polypeptides (80 amino acids), termed saposins [1] [2] [3] [4] . These four tandemly encoded saposins A, B, C and D interact with glycosphingolipid hydrolases and\or their substrates to enhance lysosomal hydrolytic activities. Their physiological importance is shown by severe phenotypes resulting from inherited mutations at the prosaposin locus that lead to deficiencies of prosaposin or individual saposins, and glycosphingolipid storage [5] [6] [7] [8] [9] [10] . Extracellularly, the intact prosaposin precursor functions ex i o or in i o as a neurite-outgrowth factor or nerve-regeneration factor respectively [11] [12] [13] [14] . The neurite-outgrowth property has been localized to the saposin C region of prosaposin, particularly to a 21-amino acid linear sequence in the N-terminal half of saposin C [11, 13, 15] .
In addition to these multifunctional properties, prosaposin is temporally and spatially regulated at the transcriptional and post-translational levels [3, 16] . Concordant high-level expression of its mRNA and protein has been shown in neurons of the central nervous system (CNS), particularly in Purkinje cells of the cerebellum in adult mice, and in various epithelioid and reproductive cell types in adult mice and rats [16] [17] [18] . The expression of prosaposin also was induced by p21, a cyclin-dependent kinase inhibitor, and serum starvation during cell-growth arrest [19] . Prosaposin is a major protein produced by Sertoli cells and has been termed sulphated glycoprotein 1 [18] . Post-translationally, the proteolytic processing of prosaposin and the Sp1 cluster from the longer constructs with 2400 bp of 5h-flanking DNA significantly diminished expression in the CNS. The appearance of substantial visceral tissue (e.g. liver, spleen, lung, kidney, thymus and heart) expression was obtained with transgenic mice bearing constructs with 742-2400 bp of 5h-flanking DNA. The cellular localization of luciferase reportergene expression from these constructs corresponded closely with that for prosaposin. These results define important CNS and visceral regulatory regions in the promoter in i o and may be sufficient to account for the majority of prosaposin's tissuepreferential expression.
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also has cell-type specificity, particularly in the CNS [3, 16] . This variation in the proteolytic processing to mature saposins is celldifferentiation-specific for human and mouse neuronal-like cell lines in culture [3] .
To initiate evaluation of the transcriptional control of the prosaposin locus, the genomic structure, particularly of the 5h end of the gene, was defined [20] . The human and murine genes contain 14 exons and 13 introns [21] [22] [23] . An alternatively spliced 9 bp ' exon ' is present in the saposin B region that appears to have tissue selectivity for splicing [21, 24] . Studies in itro indicate that the mouse prosaposin promoter is TATA-less, with positive and negative regulatory elements in the first 2400 bp 5h to the transcription start site [20] . An important region within the first 310 bp 5h to the transcription-initiation site contains functional binding elements for RORE [retinoic acid-receptor-related orphan receptor α subunit (RORα)-binding element], Sp1 and at least one additional unidentified region. These three regions modulate the expression of prosaposin in itro [25] .
To elucidate the in i o elements responsible for the tissuespecific expression of prosaposin, transgenic animals bearing fragments 5h to the prosaposin coding sequence were coupled to the luciferase reporter gene. Here, the results of analyses in transgenic mice delineate important prosaposin promoter regions for CNS and\or visceral expression.
MATERIALS AND METHODS

Materials
The following were from commercial sources : Geneclean DNA purification kit (Midwest Scientific Laboratory, Valley Park, MO, U.S.A.) ; Magna Charge Nylon transfer membrane (Micron Separation, Westbond, MA, U.S.A.) ; random-primer labelling
Figure 1 Schematic representation of the mouse prosaposin promoter region, transgenic constructs and segregation of promoter function
Various deletion fragments of prosaposin promoter 5h-flanking DNA were fused with the luciferase reporter gene. The sizes of deletion fragments are indicated by the transgenic construct name on the right. The binding sites for transcription factors (open symbols) were identified by in vitro analyses [25] . Putative transcription-factor-binding sites (closed symbols) were found by computer searches. The preferential visceral and CNS components of the promoter are indicated by the data in Table 1 and Figure 4 . The dashed line at the top indicates the indeterminate boundary for the initiation of visceral promoter activity and CNS modulatory activity. U, unknown transcription-factor-binding site ; AP-1, activator protein 1 ; RORα, retinoic acid-receptor-related orphan receptor α subunit ; SRY, sex-determining region Y. . Rabbit anti-mouse prosaposin antiserum was described previously [3] .
Transgene constructs
The firefly luciferase reporter-gene vector pGL2B was used for transgenic constructs. Based on the 5h-flanking sequence of the mouse prosaposin gene, a series of PCR primers containing restriction-enzyme sites on the 5h ends were designed for making deletion constructs [20] . Following restriction digestion, the PCR products were cloned into the HindIII and XhoI sites of pGL2B upstream of the luciferase gene. Six deletion fragments of the proximal promoter of the prosaposin gene were used and termed k43 LUC, k234 LUC, k305 LUC, k310 LUC, k741 LUC and k2400 LUC (Figure 1 ). An internal deletion construct was generated by cloning the PCR fragment containing nucleotides from k2400 to k311 into the 5h upstream region of k43 LUC. This construct was termed 2400∆LUC and did not contain RORE and the Sp1-cluster regions (Figure 1 ).
Generation of transgenic mouse lines
Each transgene construct was digested with BamHI and SmaI to include the downstream luciferase polyadenylation signal and the upstream prosaposin promoter sequences. The linearized insert was isolated by agarose gel electrophoresis, eluted and further purified twice with the Geneclean DNA purification kit. Following dialysis overnight at 4 mC in 10 mM Tris\HCl (pH 7.4) containing 0.1 mM EDTA, the DNA (1-5 ng\µl) was injected into the pronuclei of fertilized eggs of B6C3 F " mice using standard procedures [26] . Transgenic pups (21 days) were identified by Southern blotting from tail clips and bred with wild-type B6C3 mice to obtain hemizygotes.
Southern-blot analysis
Genomic DNA was isolated [27] and digested overnight with HindIII and P uII. The fragments were resolved on 0.8 % (w\v) agarose gels and transferred to Nylon membranes (Magna Charge Nylon transfer membrane). The [α-$#P]dCTP randomly labelled 310 bp fragment immediately 5h to the transcriptioninitiation site was used as the probe. Hybridizations were overnight in 50 % (v\v) formamide, 6iSSC (where 1iSSC is 0.15 M NaCl\0.015 M sodium citrate), 5iDenhardt's (0.02 % Ficoll 400\0.02 % polyvinylpyrrolidone\0.002 % BSA) and 0.3 mg\ml herring sperm DNA. The filters were washed in 0.2iSSC\0.1 % (w\v) SDS, and exposed to X-ray film. The copy number of each transgenic line was determined by comparison of blot hybridization intensities of the digested transgene fragment with those obtained with the endogenous prosaposin genomic fragment. The autoradiograms were quantified by densitometric scanning using Molecular Dynamics ImageQuant software.
Luciferase activity and protein concentration
Tissues were harvested from non-transgenic and transgenic mice between 6 and 10 weeks of post-natal age and included cerebrum, cerebellum, kidney, liver, lung, spleen, eye, heart, thymus, testes and uterus\ovary. Organs were pulverized under liquid N # and homogenized in reporter lysis buffer (Promega). The supernatants from tissue homogenates were assayed for luciferase activity using the Promega assay system and a Monolight 2010 luminometer (Analytical Luminometer Laboratory, San Diego, CA, U.S.A.). The linearity of the luciferase assay was verified for all samples assayed under the conditions used in these experiments. The protein concentration of each supernatant was determined using the Bradford reagent system.
In situ hybridization
A 0.75 kb luciferase cDNA fragment, released by EcoRI and EcoRV from pGL2B, was cloned into pBluescript vector and used to generate luciferase riboprobes. Radiolabelling of luciferase and prosaposin riboprobes was as described in [16] . The frozen sections (7 µm) of transgenic mice with the k310 LUC or k2400 LUC constructs were postfixed in 4 % (w\v) paraformaldehyde, treated with proteinase K, and then incubated in Tris\glycine and acetylated. Prehybridizations were at 42 mC for 15 min. The sections were hybridized (42 mC overnight) with 4i10( c.p.m.\ml of the complementary antisense or sense probes. After hybridization, the slides were washed with SSC\ dithiothreitol and then incubated in RNase A and RNase T1. A series of high-stringency washes was employed as described in [16] . After dehydration with graded ethanol washes, the slides were dipped in Kodak D19 developer and fixer. All slides were counterstained with haemotoxylin and eosin. The sections with sense probes were the negative controls.
Immunofluorescence
The embedded tissue sections were incubated in 0.2 % (v\v) Tween 20 in PBS at room temperature (10 min) and then covered (30 min) with blocking buffer [3 % (w\v) gelatin in PBS for antiprosaposin antibody or 10 % (v\v) goat serum for anti-luciferase antibody]. This was followed by incubation (1 h, 37 mC) with 1\100 diluted primary antiserum in 0.05 % (v\v) Tween 20 in PBS (TPBS) for anti-mouse prosaposin or 3 % (w\v) BSA\3 % (v\v) goat serum for anti-luciferase. The tissue sections were washed three times (15 min) in TPBS at room temperature. Secondary FITC antibody, diluted 1\20 in TPBS, was applied and incubated (1 h, 37 mC). The sections were washed as above. Antifade\propidium iodide was added and the signals detected by fluorescence microscopy.
RESULTS
Establishment of transgenic mouse lines and analysis of transgene expression
The role of tissue-preferential regulatory elements within 2400 bp of the 5h-flanking region of the mouse prosaposin promoter was investigated in i o using seven deletion constructs fused to the luciferase reporter gene. Each transgene construct contained 5h-flanking sequence with k43 to k2400 bp 5h to the transcription-initiation site and 98 bp of the 5h untranslated region within the first exon ( Figure 1 ). The k43 LUC construct contained the first 3h Sp1-binding site whereas the k234 LUC construct also had a RORE site. The k310 LUC construct included a Sp1 cluster of three overlapping Sp1 half sites and an unknown (U) transcription-factor-binding site. The k310 LUC and k305 LUC were identical except that k305 LUC had a 5 bp deletion within the Sp1 cluster that eliminated the most 5h Sp1 half site. The k742 LUC and k2400 LUC constructs had increasing 5h lengths of promoter region up to 2400 bp from the transcription start site. To evaluate the function of RORE and the Sp1 cluster in i o, the internal deletion construct k2400∆LUC was designed to eliminate RORE and the Sp1-cluster regions. Transgenic founders were made from each of the seven constructs ( Figure 1) . From each founder, the yield of mouse genotypes conformed to Mendelian expectations, indi-
Table 1 Luciferase activity in transgenic mice with deletions in the prosaposin promoter region
The tissue extracts were taken from F 1 or F 2 offspring at ages of 6-10 weeks. Results of multiple independent transgenic lines are shown. The transgenic lines with no luciferase expression were excluded from the data. The copy number is the number of transgenes per mouse genome. Activity levels that were less than the detectable limit are marked as 0. ND, not determined. [28] . The transgene copy numbers for each construct are listed in Table 1 . HindIII\P uII digests of tail DNA were used to quantify the copy number of integrated constructs. From the endogenous promoter, a 1.1 kb fragment was obtained and variously sized fragments are obtained from the different transgenes (Figure 2) . On the Southern blot the 310 bp probe immediately 5h to the prosaposin transcription-initiation site was used to standardize integrands since this fragment hybridizes to all constructs and the endogenous promoter fragment. The densitometric scans from two or three mice were averaged for each transgenic line. The intensities of equal molar amounts of each transgene and the endogenous promoter would be the same since the probes and recognition sequences are identical for all. The copy numbers were calculated as the ratio of the intensity of the transgene relative to that of the endogenous 1.1 kb fragment and presented as the number of transgenes per mouse genome.
To determine the effect on the tissue expression patterns of various 5h regions of the prosaposin gene, the luciferase activities in variety tissues from transgenic mice were evaluated ( Table 1) . The tissue-selective expression patterns for each construct were consistent, but the expression level varied widely between founder lines. In comparison for each transgenic founder line, the level of expression in and among various tissues was consistent, i.e. either low, intermediate or high levels of luciferase activity expression were maintained proportionately in the various tissues. The results are the means from several animals in each line and for each tissue, and are normalized for gene copy number. The non-transgenic mouse controls had no luciferase activity.
Figure 2 Southern-blot analysis of F 1 transgenic offspring
Genomic DNA was subjected to digestion with Hin dIII and Pvu II and Southern-blot analysis using the 310 bp fragment immediately 5h to the prosaposin transcription-initiation site. One representative transgenic F 1 mouse from each construct is shown. The transgenic inserts (upper bands, 3 kb) are from the F 1 mice containing the transgenic construct and are indicated at the bottom. Lane NT, DNA from a non-transgenic mouse. The sizes of the transgenes and endogenous prosaposin gene fragments (1.1 kb) are indicated on the right. The transgene copy number was quantified by densitometric comparisons of the transgene to the endogenous prosaposin fragment.
CNS-preferential expression directed by the k43 to k310 bp region
From the results in Table 1 , the CNS-preferential expression for the constructs k234, k305\k310, k742 and k2400 LUC was evident, even with the substantial variation in the levels of promoter activity that were observed between the different transgenic founder lines for each construct. The 234 bp 5h-flanking sequence is sufficient to direct CNS (cerebrum, cerebellum and eye)-preferential expression. With progressive sequence extension to 2400 bp 5h of prosaposin promoter, the luciferase activities were greatly increased. Figure 3 shows the comparison of luciferase expression in cerebrum and cerebellum in one of the transgenic lines from each construct. With the k305 LUC construct, the luciferase level was increased over 8-fold by inclusion of the Sp1 sites 5h of RORE. The substantially enhanced activities also were seen in the constructs k310 LUC, k742 LUC and k2400 LUC ; the expression levels in cerebrum or cerebellum were increased by over 35-to 100-fold relative to those for the k234 LUC construct. The results suggested that the region from k234 to k2400 bp appears to contain enhancer activities that augment the level of expression in cerebrum and cerebellum. Expression levels for k310 LUC were about 4-fold higher in cerebrum and 6-fold higher in cerebellum than those for k305 LUC (Table 1 and Figure 3 ). This may indicate that the enhancer activity in CNS requires all three of the Sp1 half sites in the cluster. However, this could not be proved due to only a single transgenic line with the k310 LUC construct being obtained.
RORE and the Sp1 cluster are located within the region k43 to k310 bp of the promoter and their roles were defined ex i o by site-directed mutagenesis [25] . The function of this region was analysed in i o by comparing the results with the k2400 LUC and k2400∆LUC constructs. As shown in Figures 3 and 4 , the expression levels in CNS tissues, including cerebrum, cerebellum and eye, were lower by 67-83 % with the deletion construct k2400∆LUC than with k2400 LUC. The luciferase expression in spinal cord was also analysed from most transgenic lines for these two constructs. Unpaired Student's t tests of five or four transgenic lines, respectively, for constructs k2400 LUC or k2400∆LUC (P 0.05) indicated significantly reduced expression levels due to the deletion of the k43 to k310 bp region (Table 2 ). This result indicates that RORE and the Sp1 cluster are necessary for maximal prosaposin expression in CNS. This deletion did not abolish the expression in CNS tissues, suggesting that other elements in the k310 to k2400 bp region are involved in modulating the basal prosaposin gene expression in the CNS.
Taken together, these results demonstrate the importance of the k43 to k310 bp region for preferential CNS expression. Both RORE and the Sp1 cluster affect prosaposin expression in the cerebrum, cerebellum, eye and spinal cord. RORE is involved in directing CNS-preferential expression and the Sp1 cluster possibly plays a role in enhancing the expression level. Additional CNS modulator activities reside in the sequences from k310 to k2400 bp of the 5h region.
Visceral tissue-selective expression on promoter construct
To define prosaposin promoter activity in visceral tissues, luciferase levels were analysed in the transgenic mice. The k43 LUC transgenic animals had extremely low to no expression of luciferase in any tissue of any of the transgene founders, indicating
Figure 4 Deletion of RORE and the Sp1 cluster region reduced the luciferase expression in CNS tissues
Five or four transgenic lines for constructs k2400 LUC (black bars) or k2400∆LUC (hatched bars) were analysed for luciferase activities in cerebrum (A), cerebellum (B), spinal cord (C) and eye (D). Results are meanspS.E.M. from three to seven mice in each transgenic line. The unpaired Student's t test was used to analyse the significance of luciferase-level differences between constructs k2400 LUC and k2400∆LUC, each with multiple transgenic lines. P values for t test analysis in each tissue are shown in Table 2 . RLU, relative light units. that the first Sp1-binding site alone is not sufficient to drive prosaposin expression in i o. Beginning with k234 LUC and increasing the length of the 5h-flanking region up to 2400 bp, an increasing gradient of expression was observed, first in the CNS regions and then, with increasing promoter length, in visceral tissues (Table 1 ). The visceral organs from the mice with the k234 LUC construct had no or negligible luciferase activity, except for a low level of expression in ovaries and uteri. The k310 LUC\k305 LUC constructs gave minimal expression in visceral organs in two out of five lines, except for in the heart (i.e. lines 1.1 and 2.1). With the k742 LUC and k2400 LUC constructs, consistent levels of expression were noted in visceral organs in all founder lines. In these visceral organs, the largest effects of the 742 and 2400 bp fragments were also in the heart. Substantially lower activities were found consistently in thymus, lung, kidney, liver and spleen. In particular, the liver had the lowest levels of expression of visceral organs on a consistent basis. The deletion construct k2400∆LUC gave substantially lower expression levels in the CNS, including the cerebellum, cerebrum, eye and spinal cord (Figure 4) . Compared with construct k2400 LUC, this internal deletion had no significant effect (P 0.05) on luciferase expression in visceral tissues or reproductive organs (results not shown), except in spleen (Table  2 ). These findings suggest that the 5h-flanking sequence between k310 to k2400 bp may have modulators or the control of visceral tissue expression.
Tissue-specific localization of luciferase and prosaposin expression
Since the transgene k310 LUC (line 1.1) showed essentially only CNS expression and k2400 LUC (line 4.2-1) had CNS and visceral expression, the tissues from mice containing these transgenes were used to localize luciferase RNA or protein expression. In similar sections from the same mice, the antisense mouse prosaposin RNA was used for co-localization. In the k310 LUC mice, neurons of the cerebral cortex and spinal cord showed concordant luciferase ( Figures 5A and 5B) and prosaposin RNA (results not shown) expression. The latter corresponded to the patterns reported for prosaposin [16] . In the eye In (E) and (F) heart sections from k2400 LUC transgenic mouse were probed with antisense (E) or sense (F) luciferase RNA. A general pattern of luciferase RNA expression (E) above background (F) was detected. In (G) and (H), immunofluorescence was detected in Purkinje cells (p) of cerebellum from k310 LUC transgenic mice using anti-luciferase (H) or anti-mouse prosaposin (G) antibodies.
( Figure 5 D) , the luciferase mRNA expression was detected in the cells of the ganglion layer (g) and was nearly absent in the inner nuclear layer (i) of retina. These patterns were comparable in distribution with those for prosaposin ( The visceral tissues from mice carrying the k2400 LUC construct (line 4.2) were examined for luciferase expression patterns. The cardiac myocytes showed low-level, diffuse luciferase RNA signals (Figure 5 E) compared with the sense control ( Figure 5 F) . This was not observed for prosaposin [16] . Using anti-luciferase antibody, low-level immunofluorescence signals were detectable in macrophages of thymus, spleen and lung (results not shown). Cell-specific luciferase expression in other tissues could not be evaluated since signals were not detected with antisense RNA or antibody to luciferase even though substantial luciferase activity was present consistently.
DISCUSSION
As with many lysosomal proteins, prosaposin has been thought to be a housekeeping gene with generalized expression. Previously, we showed great variation in prosaposin mRNA levels among various mouse tissues during development and in adulthood [16] . In particular, expression was high in CNS neurons [16, 29] , where the greatest levels of expression were found in cerebral neurons and cerebellar Purkinje cells. Sertoli cells of the testes also showed high-level expression. Transfection of deletion\reporter-gene constructs into NS20Y, NIH 3T3 and SF-7 cell cultures showed positive regulation, but with cooperative interacting elements within the first 310 bp 5h to the transcription-initiation site [20] . In addition, DNase I footprinting and site-directed mutagenesis analyses revealed several functional transcription-factor-binding elements within this 310 bp fragment, including Sp1, a Sp1 cluster, RORE and an unknown (U) site [25] . The repertoire of these transcriptionfactor-interactions was postulated to modulate gene expression [25] . However, the ex i o data did not account for the tissuepreferential expression, since similar patterns of reporter gene expression were seen in a variety of cell cultures for many elements contained in the 2400 bp 5h to the major transcription start site [20] . The present transgenic mouse analyses show that the preferential CNS or visceral tissue promoter elements were localized to the proximal 310 bp and more distal 5h-flanking regions respectively. Cellular localization of the transgenes with the luciferase mRNA also provides strong evidence for the presence of selective CNS promoter regions within the 310 bp region immediately 5h to the major transcription start site.
Increasing the length of the promoter region from k310 to k2400 bp was accompanied by the appearance of broad-based expression throughout the viscera. There was substantial variation in the levels of luciferase activity and RNA detected across different transgenic mouse lines. The positional effects of transgenes randomly integrated into the genome might account for such variation [28] . However, the patterns of activity expression within the various tissues were consistent. Computer searches across this region did not identify any major transcriptionfactor-binding sites that are known to be tissue-specific or to promote particular patterns of expression. The majority of predicted sites have activator protein 1 (AP-1), chicken homeobox gene of the caudal type (CdxA) and Oct -1 consensus sequences. These are general transcription factors that are not specific to the CNS or viscera. DNA footprinting in itro did not reveal DNase I protection of these sites within the 310 bp segment with several mouse cell types from visceral sources, nor with NS20Y neuroblastoma cells [25] . The corresponding region from the human promoter contained AP-1 and Oct-1 sites that were protected by nuclear extracts from H441 cells, a human lung papillary adenocarcinoma cell line [30] .
The deletion of RORE and the Sp1 cluster decreased the expression level of luciferase activity in CNS tissues. However, there remained a general lower level of expression that supports the existence of additional modulator sequences for CNS expression in this extended region (k310 to k2400 bp). Computer searches across the region from k742 to k2400 bp revealed the presence of several transcription-factor-binding sites, including Brn-2 and Oct-6 (Tst-10), which function as facilitators in the CNS (Figure 1 ). Oct-6 is involved in peripheral nervous sytem and CNS myelination [31] . Brn-2 is important to the development of the hypothalamus\posterior pituitary axis [32] . Another explanation for the remaining luciferase activity in CNS with the deletion construct k2400∆LUC is the possibility of RORE and\or the Sp1 cluster controlling expression in specific cell types in the CNS that would not be obvious from tissue homogenates.
These results implicate the presence of a tissue-preferential modulator(s) sequence in the region from k43 to k2400 bp. A schematic representation (Figure 1) is provided for the promoter of the mouse prosaposin gene. The data from transgenic mice are consistent with a necessary region of $ 310 bp of the immediate 5h-flanking sequence for preferential expression within the CNS. Extending more 5h to this CNS region, additional CNS regulatory elements are present and visceral activity is promoted. Finally, a general facilitator element is present within the 1700 bp 5h to the k742 LUC construct. This region is populated with a variety of sequences, none of which are known to have specific regulatory effects on lysosomal enzymes or prosaposin. Continuing studies of this promoter region should facilitate the delineation of prosaposin expression and function by preferential rescue approaches.
